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An understanding of the mechanism of immunological tolerance remains a  major 
unsolved problem. The establishment of two main classes of lymphocytes, the bone 
marrow-derived B cell and the thymus-derived T  cell and the delineation of their role 
as obligatory collaborators in many humoral responses (1)  have directed theories of 
tolerance to considerations of whether similar mechanisms of tolerance operate at both 
the B- and T-cell level (2), or whether indeed tolerance exists at the B cell level at all 
(1). Recent work has shown that T  cells may have an active suppressor role in toler- 
ance at the level of the whole animal by preventing B-cell activation (3, 4). 
An experiment of nature excluding T-cell-governed tolerance as a unique explana- 
tion for self-tolerance situations, is the example of the "nude," congenitally athymic 
(nu/nu)  mouse that is deficient in detectable T-cell function (5, 6), but which as ob- 
served by Ada and Cooper shows no obvious stigmata of autoimmunity (7). The nude 
mouse would  seem  to be an  ideal model then for the elucidation of non-T-cell-de- 
pendent mechanisms of tolerance induction at the B  cell level. Since an athymic en- 
vironment is compatible with immunological harmony these mechanisms are probably 
important in physiological self-tolerance. Bretscher and Cohn  (8)  proposed a  mech- 
anism of discrimination between activation and inactivation in terms of two signals, 
antigen-receptor interaction alone being an  obligatory signal for paralysis, antigen- 
receptor interaction plus a second signal given by associative antibody being required 
to produce activation. In the case of the B  lymphocyte, their theory states that ac- 
tivation  is  via  antigen-receptor interaction  plus  interaction  with  a  T-cell-derived 
associative antibody (8). Recently, evidence has been presented that the activation of 
the  B  lymphocyte may  indeed  be  by  a  two-signal mechanism  (9).  However,  the 
experimental situation, since nude mice were used, would seem to preclude the obliga- 
tory role of the T cell in providing such a signal (9). Furthermore, short term exposure 
of B  lymphocytes in vitro to antigen alone, a  situation equivalent to the sole para- 
lyzing "signal one"  of Bretscher and  Cohn,  did not produce tolerance, although no 
immune response was seen unless a form of "signal two" was added subsequently (10). 
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In the experiments reported here the possibility was therefore examined that 
interaction in vivo of the B  lymphocyte with antigen alone in the absence of 
T  cells, and for a variety of time spans, might induce tolerance. 
Materials and Methods 
Animals.--Congenitally athymic (nu/nu) nude mice were used at 6-8 wk of age. The mice 
were from a closed but not inbred colony (6). CBA/H/Wehi mice were used at 8 wk of age. 
Anligens.--Fowl gamma globulin (FGG), 1 a thymus-dependent antigen (11) was prepared 
and deaggregated as described previously (9). Flagella (FLA) or polymerized flagellin (POL) 
were prepared from Salmonella adelaide by a standard method (12). 
Dinitrophenylated-POL  (DNP-POL)  and  dinitrophenylated  human  gamma  globulin 
(DNP-HGG)  were prepared  using  dinitrobenzene  sulphonic acid  (Eastman Kodak  Co., 
Rochester, N. Y.) (13). The average conjugation ratio of the DNP-POL was 1.5 DNP groups 
per unit of monomeric flagellin (40,000 daltons). The preparations of DNP-HGG used in this 
study had conjugation ratios of 4.5 and 20 DNP groups per HGG molecule. 
Antibody.Forming Cell (AFC) Assays.--Anti-FGG  AFC  were assayed by  a  modified 
hemolytic plaque technique, using sheep erythrocytes  (SRC) coated with an anti-SRC anti- 
body raised in the domestic fowl, as described previously (11, 9). Anti-DNP AFC were assayed 
by a modified hemolytic plaque assay using SRC coated with dinitrophenylated  rabbit anti- 
SRC-Fab fragments (13). Indirect plaque-forming cells (14) were revealed using a polyvalent 
rabbit anti-mouse immunoglobulin serum, donated by Dr. Pare  Russell, and shown in pre- 
liminary  experiments to efficiently  reveal IgG-secreting AFC, generated in secondary responses 
both in vivo and in vitro. 
Tissue Culture.--A modification of the Marbrook system was used (15). The medium em- 
ployed was Eagle's Minimal Essential Medium, with added nonessential amino acids (Cat. 
no. F-15, Grand Island Biological Co., Grand Island, N.  Y.)  supplemented with 5% fetal 
calf  serum  (Commonwealth Serum Laboratories,  Parkville,  Australia).  Cultures  were in- 
cubated for 3 or 4 days in 10% COs and humidified air. 
Clearance of FGGfrom the Blood.--Groups of mice were injected i.v. with 5 mg of FGG, 
containing trace amounts of 12~I-labeled  FGG (16). 90 rain later the first blood sample was 
taken from the tail vein using a microhaematocrit tube (Yankee, A-2930, Clay-Adams, Inc., 
Parsippany, N. J.). The length of the blood column was measured and counts per millimeter 
were calculated from the total disintegrations per 10 s per haematocrit tube, as determined in 
a deep-well scintillation counter. 
RESULTS 
The Effect of In  Vivo Injection of i.v. Deaggregated  FGG on the In  Vitro Re- 
sponse to FGG of nu/nu Spleen.--Nude  mice were injected i.v. with  10 mg of 
deaggregated  FGG in saline. After  9  days  the  mice  were  sacrificed  and  the 
ability of the spleen cells to respond to FGG in vitro was tested. As  described 
previously nu/nu spleen cells respond to deaggregated or normal FGG in vitro 
if polymerized flagellin (POL)  or flagella (FLA)  are present (9). Accordingly 
the spleen cells to be challenged were cultured with  100 #g FGG plus 10  tzg 
POL  or  FLA,  together  with  a  second  antigen DNP-POL.  The  response  to 
1  Abbreviations used in t.~is  paper: AFC, antibody-forming cell; B cell, bone marrow-derived 
lymphocyte;  DNP-HGG,  dinitrophenylated  human gamma  globulin; DNP.POL,  dinitro- 
phenylated polymerized flagellin; FGG, fowl gamma  globulin; FLA,  flagella; POL, polym- 
erized flagellin; SRC, sheep erythrocytes; T cell, thymus-derived lymphocyte. JOHN  W.  SCHRADER  1305 
DNP-POL is thymus independent (16) and served as a specificity control. 3,  or 
in  some  experiments 4,  days later the  cells were  harvested  and  assayed  for 
anti-FGG antibody-forming cells (AFC) and anti-DNP-AFC. It was found that 
the anti-FGG AFC response was markedly reduced in cultures of spleen  cells 
from  FGG-treated animals,  while  the  response  to  an  unrelated  antigen,  the 
DNP  determinant of DNP-POL,  was not significantly different from that  of 
spleen cells from control animals (Table I). In no  experiment did the  use of 
enhancing  serum  in  the  anti-FGG  AFC  assay  reveal  any  indirect  plaque- 
forming cells (14). 
The Effect  of In  Vivo  Injection  of DNP-HGG on  the In  Vitro  Response  to 
DNP-POL.--In the reverse experiment to the  above, soluble DNP-HGG  was 
injected into nu/nu mice in vivo in doses from  5  to  10  rag.  1-9  days  later, 
the  spleens were removed  and  challenged in vitro with DNP-POL,  this  time 
with FGG, in the presence of POL, being the control antigen. Table II shows 
TABLE I 
The Induction  of Tolerance In Vivo in Athymic Mice 
Donor of cells 
AFC/culture 
Anti-FGG  Anti~NP 
Untreated  558  4-  96  300  4-  33 
Treated with FGG in vivo  72  4- 66  321  4- 45 
Athymic (nu/nu) mice were injected i.v. with 10 mg of freshly deaggregated FGG. 9 days 
later the spleens were removed  and the cells cultured for 4 days in the presence  of FGG 
(100 Dg/ml), DNP-POL (1 #g/ml), and POL (10 #g/ml). Spleen cells from untreated athymic 
(nu/nu) mice were cultured in parallel as a control. 
TABLE II 
Induction of Unresponsiveness in DNP-specifw B cells 
Pretreatment of_donor 
AFC/cuhure 
Anti-DNP  AntioFGG 
Exp. I  --  459  4-  60  465  4-  102 
DNP4.~-HGG, 5 mg*  0  540  -4-  102 
DNP4.5-HGG, 5 mg~  0  450  4-  26 
Exp. II  --  122  ±  60  333  4-  133 
DNP20-HGG, 10mg$  10  4-  4  322  :t:  58 
Groups of nu/nu mice were injected i.v. with two preparations of soluble DNP-HGG with 
the indicated conjugation ratios. ~lhe DNP-HGG had been deaggregated and stored at 4-8°C 
for 1 wk (DNP4.~-HGG), and 26 wk (DNP20-HGG), respectively. After 4 days (*), or 3 days 
($), mice were killed and the spleens cultured with DNP-POL(1/~g) (different batches were 
used in exps. I and II), FGG (100/~g), and POL (10 #g). Cultures were harvested after 3 days 
and each was assayed for anfi-DNP and anfi-FGG AFC. 1306  TOLERANCE  INDUCTION  IN  ATHYMIC  ~ICE 
representative  results  with  two  preparations  of  DNP-HGG  indicating  that 
the induction of nonresponsiveness was not peculiar to FGG. 
Route of Injection and State of Aggregation  of FGG.--The use of freshly de- 
aggregated material  was not critical.  Thus,  solutions  of FGG  that  had  been 
deaggregated  and  then  kept  sterile  at 4-8°C  were  as effective as freshly de- 
aggregated  FGG  (e.g.,  Table  III,  exp.  I).  I.p.  injections  were  found  to  be 
regularly effective, although often the degree of unresponsiveness induced was 
less than that obtained by an i.v. injection. I.p. injection of FGG that contained 
readily visible aggregates gave the most variable results, on some occasions the 
AFC response to FGG of cultures of cells from mice thus treated, reaching 50 % 
TABLE III 
The Effect of Variation of the Route of Injection and the State of Aggregation of FGG 
Experiment  Treatment of donor mouse 
number 
AFC/culture 
Anti-FGG  Anti-DNP 
I  7.5 mg FGGi.v.*  0  231  4- 35 
Control  276  4-  52  196 4-  21 
II  7.5 mg FGG i.p.,  93  4-  60  400  +  65 
Control  350  4-  85  290  4-  65 
Nu/nu mice in groups of three were injected with (*)FGG from a deaggregated preparation 
that had stood in the refrigerator  (4-8°C) for 2 wk, or (*) FGG which was from the bottom 
fraction of a solution of FGG after ultracentrifugation  and which had been stored frozen. In 
exp. I, the spleens were taken  24 h after injection of FGG and the cells cultured  for 3 days 
with FGG (100/zg/ml),  POL 10 (#g/ml), and DNP-POL (1/zg/ml).  In exp. II, the spleens 
were taken on the 3rd day after injection  and cultured  with antigens  as above for 4 days. 
Similar results were obtained in other experiments where these variables were  tested  using 
periods between injection and culture of from 1 to 9 days. 
of control values. It was noted that the anti-DNP response tended to be higher 
in cultures of spleens from mice injected with some preparations of aggregated 
FGG, as suggested in the results shown in Table III, exp. II. 
The  Kinetics  of  the  Induction  of  Unresponsiveness  In  nu/nu  Spleen.--To 
determine  how long was needed  after  the in vivo injection of FGG for unre- 
sponsiveness to become apparent,  and to investigate the duration of the effect, 
groups of mice were injected i.v. with 7.5 mg of deaggregated FGG at varying 
times before sacrifice and culture of spleen cells. Fig. 1 demonstrates the pooled 
results  of several  experiments,  in each of which two to four time points  were 
examined.  It is  apparent  that unresponsiveness  is induced relatively rapidly, 
not being  evident  at  6 h  but  being reproducibly complete by 24 h.  The per- 
sistence  of this  effect  is  still  under  study;  however,  at  least  until  11  days, 
unresponsiveness is complete. 
The Dose of FGG Required for the Induction of Unresponsiveness.--The  effect 
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FIG. 1. The kinetics  of the induction  of unresponsiveness  to FGG. Groups of nu/nu mice 
were injected  i.v. with 7.5 mg of FGG at varying intervals before the spleen cells were cul- 
tured with FGG (100 Izg.), POL (10/zg), and DNP-POL (1 ~zg). Quadruplicate cultures were 
set up at each time point, and the results have been normalized to allow pooling of data from 
different  experiments.  Thus,  each  point  represents  the percentage decrease  of  the  mean 
response of four experimental cultures, below the mean anti-FGG response of cultures of spleen 
cells from untreated mice. In all cases the anti-DNP responses of the experimental cultures 
were equivalent to those of the control cultures. 
found that 5 mg was required to consistently induce unresponsiveness,  amounts 
less than  1 mg being ineffective. Fig. 2 shows the effect of varying the dose of 
FGG, given i.v. 5 days before in vitro challenge. 
Susceptibility  of  the  Unresponsive State  to  Breakage  by  Allogeneic 
Confrontation.--There are several reports of states of specific unresponsiveness 
being  terminated  by  confrontation  with  allogeneic  cells  (17).  Therefore,  the 
effect of adding to unresponsive spleen cells a source of T  cells which recognize 
the  nu/nu  cells  as  allogeneic  was  investigated.  Spleen  cells  from  CBA  mice 
contain T  cells that recognize as aUogeneic the nu/nu spleen cells obtained from 
members of the Hall Institute nude mouse colony (6, 18). Previously it has been 
shown that the release of factors amplifying AFC responses is not affected by 
pretreating the CBA spleen cells with doses of mitomycin C that inhibit thymi- 
dine uptake  (18). As would be expected the mitomycin C-treated  CBA spleen 
cells do not themselves contribute  to an anti-FGG AFC response  (18).  Fig. 3 
shows a  typical result.  In no experiment was there  any evidence that the un- 
responsiveness was abrogated by confrontation by allogeneic cells, while in con- 
trol, nontolerant cultures, the expected amplification effect was noted. 1308  TOLERANCE  INDUCTION  IN"  ATHY~IC  MICE 





CONTROl.  0.0325  0"325  3.25  7"5 
FGGlmg) 
FIG. 2. The dose of FGG required for the induction of unresponsiveness. Deaggregated 
FGG was injected i.v. in the indicated doses. 5 days later spleen cells were challenged in vitro 
with FGG (100 #g), POL (10/zg); and DNP-POL (1/zg). The data from two experiments is 
shown; each point represents the mean responses of four or eight cultures. The anti-DNP 
responses were equal in all groups. 
The  :Effect on  the Induction  of the  Unresponsive State  of the Simultaneous 
Injection of POL with FGG.--It has been proposed that POL provides a "second 
signal" required  for the  activation  of ]3  cells by FGG when  T  cells are not 
present (10). Therefore, it was of interest to see whether the induction of the 
unresponsive state in vivo could be prevented by giving POL together with the 
deaggregated FGG. Fig. 3 illustrates the results of one typical experiment that 
demonstrated that giving POL with i.p. injected FGG, blocked the induction of 
unresponsiveness. In other experiments of similar design POL, 10/~g. i.p., also 
substantially reduced the specific unresponsiveness induced by the i.v. injection 
of FGG. 
The Effect of Delaying the Injection of POL after Pretreatment with FGG.--To 
determine how long an exposure to antigen in vivo was required  before unre- 
sponsiveness was no longer reversible by the addition of POL, a large group of 
nu/nu  mice was injected  with  FGG,  7.5  mg i.v.  Mice were then injected  in 
groups of three with POL,  i.p.  10 ~g,  either within  5-10 rain or at intervals 
thereafter. Mter 2-6 days the mice were killed and  the spleen  cells cultured 
with FGG, POL, and DNP-POL. As shown in Table IV, the injection of POL 
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FIG.  3.  The abrogation of tolerance induction by the administration of POL with FGG 
and the lack of effect of allogeneic confrontation on the unresponsiveness to FGG. Groups of 
nu/nu mice were injected i.p. with 5 mg FGG or with 5 mg FGG i.p. together with 10/~g 
POL i.p. 5 days later the mice were sacrificed and portions of spleen cell  suspensions were 
challenged with FGG,  POL, and DNP-POL. The anti-FGG responses of these groups together 
with that of spleen cells from untreated mice are shown by the solid columns.  Anti-DNP 
responses were equivalent in these groups. Portions from each of these three spleen cell sus- 
pensions were also cultured with 3 X  10  s mitomycin C-treated (40/~g/ml for 30 rain at 37°C) 
CBA spleen cells together with FGG, POL, and DNP-POL. The anfi-FGG responses in the 
presence of CBA spleen cells are shown by the open columns. Anti-DNP responses were equiv- 
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TABLE  IV 
The Effect of the Injection of POL on the Induction of Unresponsiveness by FGG 
Pretreatment of donor 
FGG  Time to POL injection 
Anti-FGG AFC/culture 
--  --  212  4-  24 
q-  --  10  4- 35 
q-  10 min  183  4-  60 
-b  4 h  213  4-  70 
-t-  10 h  264  4-  85 
q-  24 h  63  -4- 25 
Groups of three nu/nu mice were injected i.v. with 7.5 mg of FGG. At the indicated inter- 
vals, POL (10/~g) was injected i.p. 4 days later the mice were killed and the spleens cells 
cultured for 3 days with FGG (100/zg), POL (10 ~g), and  DNP-POL  (0.1 /zg). The data 
shown represent the pooled results of three experiments. 
servation is consistent with a certain critical period of about 24 h  of exposure 
to FGG being sufficient to induce specific unresponsiveness, as long as the B cell 
is not subject to an additional influence, which diverts the response to immunity 
and which here is provided by POL. 
Clearance of FGG in the Presence of POL.--One possible explanation for the 
effect of POL in abrogating tolerance induction by FGG was that it enhanced 
removal  of  FGG  from  the  extracellular  fluid,  perhaps  by  stimulating  the 
reticuloendothelial  system.  This  point  was  approached  by investigating  the 
clearance from the blood of 125I-labeled FGG, in the presence or absence of an 
i.p. injection of POL. Fig. 4 shows that the clearance of FGG in the first 24 h 
in these two situations. It can be seen that  there  was no  significant difference 
between the two groups. Thus POL did not alter the amount of FGG present 
in the extracellular fluid during the first 24 h period that is critical for tolerance 
induction. It should be noted that in both cases the FGG is cleared rapidly, its 
half-life being about 7 h, comparable with the 11 h reported for another avian 
gamma globulin in the mouse (19). 
In Vivo Challenge of FGG-Injected  nu/nu mice.--Nu/nu mice respond in vivo 
to FGG provided that POL is injected also (unpublished data). Therefore it was 
possible to challenge the capacity of nude mice to mount an anti-FGG response 
in vivo after pretreatment with large doses of FGG. Nu/nu mice were treated 
with FGG, 7.5 mg i.v., and after 3-17 days were challenged with FGG, 100/zg, 
plus POL, 10/~g. After 3 or 4 days at which time the anti-FGG response in nude 
mice thus challenged is maximal (unpublished data), the mice were killed and 
the direct and enhanced anti-FGG plaque-forming cells per spleen were assayed. 
Table V shows the results of a typical experiment demonstrating that the deficit 
in anti-FGG response in FGG preinjected nu/nu mice is apparent on in vivo 
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FIG. 4.  The lack of effect of POL on the clearance of FGG from the blood. Nu/nu mice in 
two groups of three were injected i.v. with 5 mg of ~sI-trace-labeled FGG. One group was in- 
jected i.p. with POL, 10 #g (©), 5 min later. The data shown represent counts per  10 s  per 
unit of blood, as described above. 
TABLE  V 
The Induction of Unresponsiveness by i.v. FGG to In  Vivo Challenge  with FGG Plus POL 
Pretreatment  interval  Direct anti-FGG AFC/spleen 
days 
8  42  4-  40 
17  350  4-  100 
--*  3050  4-  600 
Nu/nu mice in groups of three were injected i.v. with FGG 7.5 mg at the indicated intervals 
before they were challenged together with a group of untreated mice (*) with FGG (100 gg) 
plus POL (10 #g) i.p. 3 days later the mice were killed and direct and indirect anti-FGG AFC 
per spleen were assayed. No indirect AFC were detected in this or in other similar experiments. 
DISCUSSION 
The present results show that B-cell tolerance to a thymus-dependent  antigen 
can  be  induced  in  the  absence  of  T  cells.  The  mechanism  of  the  functional 1312  TOLERANCE  INDUCTION  IN  ATHYMIC  MICE 
elimination of specific B-cell clones is not clear. A simple blockage of the recep- 
tors by the high  concentration of antigen would seem to be unlikely. If this 
were so the addition of POL at either the in vivo or in vitro stage of the experi- 
ment would be expected to produce B-cell activation, since, in the presence of 
POL, B cells respond in vitro to deaggregated FGG at a concentration up to at 
least  1 mg/ml (9). The fact that the addition of POL in vivo prevented the 
induction  of unresponsiveness only at  an early stage in  tolerogenesis (Table 
IV) points to the B cell undergoing some definite irreversible change. The lack 
of reversal of the  tolerance by allogeneic confrontation (Fig.  3)  is  a  further 
indication that the FGG-specific B cells may have disappeared. This would be 
consistent with the situation reported by Louis et al. (20) where B-cell tolerance 
that had been induced by a high dose of deaggregated antigen was accompanied 
by a loss of antigen-binding cells in the spleen. 
Much interest has centered on the importance of epitope density in tolerance 
induction, a high density of determinants putatively favoring tolerance induc- 
tion  (21).  In  the  case of simple protein antigens,  it has  been proposed that 
antigen-antibody complexes may supply the required epitope density (21). This 
mechanism is unlikely to be relevant in the present model, firstly, since there is 
no detectable antibody formation with  the  injection of FGG  alone into  the 
nude  mouse  (unpublished  data);  secondly,  since  the  amount  of  antigen  in- 
jected is relatively large; and thirdly, since the tolerance is established within 
24 h, before antibody synthesis would be underway. 
As FGG is a globulin, there is the possibility that binding to Fc receptors on 
lymphocytes (22) or macrophages (23) could be producing a matrix of determi- 
nants, presumably those on the Fab end of the molecule. However the anti-FGG 
antibodies detected in the plaque assay are most likely directed against the Fc 
end of the molecule, the Fab portion being bound  to the indicator SRC. In 
addition DNPl-bovine serum albumin is effective in this system, in inducing 
unresponsiveness to DNP (unpublished data). A final point, with regard to the 
physical configuration required for tolerance induction, is that FGG is made up 
of two identical heavy chains and two identical light chains, and therefore it is 
possible that a given B  cell could recognize two identical epitopes on the one 
molecule. On the evidence available then, a simple interaction of the B cell with 
antigen may suffice for tolerance induction; the present experiments however 
cannot exclude that two determinants on a molecule need bind to the B  cell. 
What are the implications of the basic observation that B-cell tolerance to a 
thymus-dependent antigen can be induced in the absence of T  cells? Firstly 
these experiments point to an alternative to T-cell-dependent tolerance mech- 
anisms (3, 4) at the level of the B cell. Secondly, they illustrate a simple mech- 
anism for the maintenance  of self-tolerance of the nude mouse to its  serum 
proteins. Teleologically it would seem very desirable that B  cells,  as well as T 
cells (24), be self-tolerant since it is clear that ubiquitous substances such as 
endotoxin (25, 26) and products from activated macrophages (18), which could JOHN  W.  SCHRADER  1313 
in theory be stimulated by infection or inflammation, allow B  cells to respond 
to thymus-dependent antigens in the absence of activated, specific T cells. Thus 
tolerance existing solely at the T  cell level could be broken (27). 
Miller et al. have reported that they were unable to tolerize B  cells using a 
high dose of FGG in normal CBA or C57 X  CBA mice (28). A comparison with 
the ease of B-ceU tolerance induction in athymic mice that was  demonstrated 
in the present study, suggests that T  cells may in fact  protect B  cells from 
tolerance induction. A difference is especially obvious where there is some degree 
of aggregation of the antigen, in which case CBA mice are primed while nude 
mice tend still to be tolerized (J. W. Schrader, manuscript in preparation). One 
explanation is that the T  cell is normally involved in the provision of a second 
signal (8, 9, 18), that diverts the B cell from becoming tolerant upon encounter 
with antigen. Tolerization of the B-cell population might await a virtually com- 
plete functional deletion of specific T  cells,  an hypothesis compatible with the 
observations of Weigle and colleagues on the relative kinetics of induction of 
tolerance in T  and B  cells (2). Experiments demonstrating B-cell tolerance to 
determinants on molecules or homologous erythrocytes which cannot activate 
specific T cells (29, 30), support the concept that the interaction of antigen with 
the B  cell in the absence of a  second signal may lead to tolerance. Thus the 
results of Miller et al. who found no evidence for B-cell tolerance using FGG 
in CBA mice (28), may be the result of the incompleteness of tolerance at the 
T-cell level which can be seen in the ability of thoracic duct lymphocytes from 
"tolerant" mice to collaborate with FGG-primed B  cells (28). 
The present model does not explain tolerance to thymus-independent antigens 
like POL, endotoxin, or pneumococcal polysaccharide. Rather it makes tolerance 
to them paradoxical since  these  substances  seem to be good adjuvants  and 
B-cell stimulants (9, 25, 26, 31), and endotoxin (32), and now POL, have been 
shown to prevent the induction of tolerance to thymus-dependent antigens. It 
is necessary to postulate that a different mechanism is involved in tolerance to 
thymus-independent  antigens.  Recently  we  have  reported new  evidence  to 
suggest that highly multivalent, thymus-independent antigens such as POL or 
DNP-POL may cause a substantial diminution of the rate of antibody secretion 
by single AFC, a phenomenon we have termed effector cell blockade.  2 We have 
suggested that some forms of nonreactivity mediated by multivalent antigens 
or  antigen-antibody  complexes might  really represent  effector cell blockade 
rather than the suppression of the potential for B-cell activation. 
SUMMARY 
Specific  immunological  unresponsiveness  was  induced  using  thymus- 
dependent antigens in congenitally athymic (nu/nu) mice, in which no T-cell 
Schrader, J. W., and G. J. V. Nossal. 1974. Effector cell blockade: a new mechanism of 
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function  has  been  demonstrated.  The  tolerance  was  induced  in  vivo by the 
injection of 5-10 mg of either FGG or DNP-HGG. 
Spleen cells from treated mice were tested in vitro for the ability to mount 
thymus-independent immune responses against FGG in the presence of polym- 
erized flagellin POL, and the DNP determinant conjugated to POL. A specific 
deficiency in either the in vitro anti-FGG or anti-DNP response was demon- 
strated, depending on the antigen used for treatment of the spleen cell donor. 
Athymic mice treated  with  FGG were also  tested  by in vivo challenge  with 
FGG given with POL as an adjuvant and were found to be hyporesponsive. 
Unresponsiveness  to  in  vitro  challenge  was  established  by  24  h  after 
the in vivo injection of FGG. It was found that the injection of POL with the 
FGG prevented the development of unresponsiveness, but not if the POL was 
given 24 h  or more after the FGG. 
The unresponsiveness could not be overcome by confrontation with allogeneic 
spleen cells from CBA mice, although the presence of allogeneic spleen cells had 
a large amplifying effect on the response of control spleen cells.  These experi- 
ments demonstrate a  mechanism for the  tolerization of bone marrow-derived 
cells by thymus-dependent antigens in the absence of the thymus. 
Mr. John Pye prepared the POL and performed the radioiodinations. Professor G. J. V. 
Nossal is thanked for helpful discussions. Ms. H. King was a valuable assistant. 
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